| Breast Cancer |  | Prostate Cancer |  |
---|---|---|---|---|
Total compounds | 3678 | Â | 4228 | Â |
Compounds that are FDA drugs | 632 | Â | 676 | Â |
Compounds that are FDA drugs for target disease | 20 | Â | 11 | Â |
Compounds that are in clinical trial for target disease | 154 | Â | 106 | Â |
 | UCDB | DCUB | UCDB | DCUB |
Compounds with FDR < 0.05 | 2435 | 1875 | 2500 | 1668 |
Compounds that are clinical drugs with FDR < 0.05 (p-value) | 131 (6.2E-8) | 109 (2.7E-7) | 82 (4.9E-5) | 67 (4.8E-7) |
FDA drugs with FDR < 0.05 | 427 | 325 | 456 | 317 |
FDA drugs with FDR < 0.05 in both UCDB and DCUB | 244 |  | 291 |  |
FDA drugs for target disease with FDR < 0.05 (p-value) | 20 (2.5E-4) | 19 (2.7E-5) | 10 (2.6E-2) | 9 (5.3E-3) |
AUC (p-value) | 0.86 (<1.0E-6) | 0.81 (<1.0E-6) | 0.77 (9E-3) | 0.83 (4.7E-5) |
Number of MAG/DRG | 237/700 | 75/100 | 333/100 | 46/100 |